Skip to main navigation menu Skip to main content Skip to site footer

Vol. 13 No. 4 (2026)
International Multidisciplinary Journal for Research & Development

Articles

FEATURES OF INFLUENZA TREATMENT IN CHILDREN WITH CHRONIC CONDITIONS

Published 2026-04-10

  • Umarova M.A.

Umarova M.A.
ASMI

Abstract

The article presents data from a study on the efficacy and safety of the drug Oselvir, a neuraminidase inhibitor, for the treatment of influenza in children with chronic cardiovascular and nervous system conditions. It was shown that Oselvir significantly reduces the duration of fever, sore throat, and cough. The treatment was associated with adverse events, but their type and frequency did not differ between the groups of children receiving different antiviral therapies. Complications were rare, with no significant differences between the groups.

Keywords

influenza, infections, virus, fever, headache, dizziness, body aches, tachycardia, cycloferon, viferon, genferon, Oselvir, tamiflu

PDF

References

  1. Kuzmina T.Yu., Tikhonova E.P. Analysis of fatal outcomes in H1N1 Swine influenza // Practical Medicine. 2011. № 3–1 (50). P. 86.
  2. Svistunova N.V. Clinical features of modern influenza and comparative analysis of antiviral therapy effectiveness: abstract of dissertation … candidate of medical sciences. Moscow, 2014.
  3. Shubin I.V., Chuchalin A.G. Diagnosis and treatment of acute respiratory viral infections, influenza, and influenza-associated pneumonia // Polyclinic. 2011. № 2–1. P. 78–81.
  4. Osidak L.V. Acute respiratory infections in children and adolescents. Practical guide for physicians. 3rd ed. St. Petersburg: InformMed, 2014.
  5. Ershov F.I. Antiviral drugs. Handbook. Moscow: GEOTAR-Media, 2006.
  6. Usenko D.V., Gorelova E.A., Kanner E.V. Rational approach to therapy of ARVI and influenza in pediatric clinical practice // Russian Medical Journal. 2015. Vol. 23. № 3. P. 174–177.
  7. Feklisova L.V., Gorelov A.V., Drinevsky V.P., et al. The role of interferon preparations in ARVI therapy in infants and young children (results of a multicenter comparative randomized clinical trial) // Pediatric Pharmacology. 2011. Vol. 8. № 5. P. 76–82.
  8. Markova T.P., Yarilina L.G. Modern antiviral therapy of influenza and ARVI // Russian Medical Journal. 2015. Vol. 23. № 4. P. 211–215.
  9. Shablakova A.S., Kovalev I.S., Rusinov V.L., et al. Methodology for analyzing the encapsulated form of the antiviral drug Triazavirin // Modern High-Tech Technologies. 2014. № 2. P. 93–95.

Downloads

Download data is not yet available.